This report contains market size and forecasts of Chronic Kidney Disease Drugs in global, including the following market information:
Global Chronic Kidney Disease Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Chronic Kidney Disease Drugs Market Sales, 2016-2021, 2022-2027, (K MT)
Global top five Chronic Kidney Disease Drugs companies in 2020 (%)
The global Chronic Kidney Disease Drugs market was valued at 11200 million in 2020 and is projected to reach US$ 11990 million by 2027, at a CAGR of 1.7% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chronic Kidney Disease Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chronic Kidney Disease Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Chronic Kidney Disease Drugs Market Segment Percentages, By Type, 2020 (%)
ACE Inhibitors
Calcium Channel Blockers
Beta Blockers
Others
Global Chronic Kidney Disease Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Chronic Kidney Disease Drugs Market Segment Percentages, By Application, 2020 (%)
Hospitals
Specialty Clinics
Global Chronic Kidney Disease Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Chronic Kidney Disease Drugs Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chronic Kidney Disease Drugs revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Chronic Kidney Disease Drugs revenues share in global market, 2020 (%)
Key companies Chronic Kidney Disease Drugs sales in global market, 2016-2021 (Estimated), (K MT)
Key companies Chronic Kidney Disease Drugs sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Keryx Biopharmaceuticals, Inc
Kissei Pharmaceutical Co., Ltd
AbbVie
GlaxoSmithKline
Sanofi
F. Hoffmann-La Roche Ltd
Pfizer
AstraZeneca
Amgen
Teva Pharmaceutical Industries
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Chronic Kidney Disease Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chronic Kidney Disease Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chronic Kidney Disease Drugs Overall Market Size
2.1 Global Chronic Kidney Disease Drugs Market Size: 2021 VS 2027
2.2 Global Chronic Kidney Disease Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Chronic Kidney Disease Drugs Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Chronic Kidney Disease Drugs Players in Global Market
3.2 Top Global Chronic Kidney Disease Drugs Companies Ranked by Revenue
3.3 Global Chronic Kidney Disease Drugs Revenue by Companies
3.4 Global Chronic Kidney Disease Drugs Sales by Companies
3.5 Global Chronic Kidney Disease Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Chronic Kidney Disease Drugs Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Chronic Kidney Disease Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Chronic Kidney Disease Drugs Players in Global Market
3.8.1 List of Global Tier 1 Chronic Kidney Disease Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Chronic Kidney Disease Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Chronic Kidney Disease Drugs Market Size Markets, 2021 & 2027
4.1.2 ACE Inhibitors
4.1.3 Calcium Channel Blockers
4.1.4 Beta Blockers
4.1.5 Others
4.2 By Type - Global Chronic Kidney Disease Drugs Revenue & Forecasts
4.2.1 By Type - Global Chronic Kidney Disease Drugs Revenue, 2016-2021
4.2.2 By Type - Global Chronic Kidney Disease Drugs Revenue, 2022-2027
4.2.3 By Type - Global Chronic Kidney Disease Drugs Revenue Market Share, 2016-2027
4.3 By Type - Global Chronic Kidney Disease Drugs Sales & Forecasts
4.3.1 By Type - Global Chronic Kidney Disease Drugs Sales, 2016-2021
4.3.2 By Type - Global Chronic Kidney Disease Drugs Sales, 2022-2027
4.3.3 By Type - Global Chronic Kidney Disease Drugs Sales Market Share, 2016-2027
4.4 By Type - Global Chronic Kidney Disease Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Chronic Kidney Disease Drugs Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Specialty Clinics
5.2 By Application - Global Chronic Kidney Disease Drugs Revenue & Forecasts
5.2.1 By Application - Global Chronic Kidney Disease Drugs Revenue, 2016-2021
5.2.2 By Application - Global Chronic Kidney Disease Drugs Revenue, 2022-2027
5.2.3 By Application - Global Chronic Kidney Disease Drugs Revenue Market Share, 2016-2027
5.3 By Application - Global Chronic Kidney Disease Drugs Sales & Forecasts
5.3.1 By Application - Global Chronic Kidney Disease Drugs Sales, 2016-2021
5.3.2 By Application - Global Chronic Kidney Disease Drugs Sales, 2022-2027
5.3.3 By Application - Global Chronic Kidney Disease Drugs Sales Market Share, 2016-2027
5.4 By Application - Global Chronic Kidney Disease Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Chronic Kidney Disease Drugs Market Size, 2021 & 2027
6.2 By Region - Global Chronic Kidney Disease Drugs Revenue & Forecasts
6.2.1 By Region - Global Chronic Kidney Disease Drugs Revenue, 2016-2021
6.2.2 By Region - Global Chronic Kidney Disease Drugs Revenue, 2022-2027
6.2.3 By Region - Global Chronic Kidney Disease Drugs Revenue Market Share, 2016-2027
6.3 By Region - Global Chronic Kidney Disease Drugs Sales & Forecasts
6.3.1 By Region - Global Chronic Kidney Disease Drugs Sales, 2016-2021
6.3.2 By Region - Global Chronic Kidney Disease Drugs Sales, 2022-2027
6.3.3 By Region - Global Chronic Kidney Disease Drugs Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Chronic Kidney Disease Drugs Revenue, 2016-2027
6.4.2 By Country - North America Chronic Kidney Disease Drugs Sales, 2016-2027
6.4.3 US Chronic Kidney Disease Drugs Market Size, 2016-2027
6.4.4 Canada Chronic Kidney Disease Drugs Market Size, 2016-2027
6.4.5 Mexico Chronic Kidney Disease Drugs Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Chronic Kidney Disease Drugs Revenue, 2016-2027
6.5.2 By Country - Europe Chronic Kidney Disease Drugs Sales, 2016-2027
6.5.3 Germany Chronic Kidney Disease Drugs Market Size, 2016-2027
6.5.4 France Chronic Kidney Disease Drugs Market Size, 2016-2027
6.5.5 U.K. Chronic Kidney Disease Drugs Market Size, 2016-2027
6.5.6 Italy Chronic Kidney Disease Drugs Market Size, 2016-2027
6.5.7 Russia Chronic Kidney Disease Drugs Market Size, 2016-2027
6.5.8 Nordic Countries Chronic Kidney Disease Drugs Market Size, 2016-2027
6.5.9 Benelux Chronic Kidney Disease Drugs Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Chronic Kidney Disease Drugs Revenue, 2016-2027
6.6.2 By Region - Asia Chronic Kidney Disease Drugs Sales, 2016-2027
6.6.3 China Chronic Kidney Disease Drugs Market Size, 2016-2027
6.6.4 Japan Chronic Kidney Disease Drugs Market Size, 2016-2027
6.6.5 South Korea Chronic Kidney Disease Drugs Market Size, 2016-2027
6.6.6 Southeast Asia Chronic Kidney Disease Drugs Market Size, 2016-2027
6.6.7 India Chronic Kidney Disease Drugs Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Chronic Kidney Disease Drugs Revenue, 2016-2027
6.7.2 By Country - South America Chronic Kidney Disease Drugs Sales, 2016-2027
6.7.3 Brazil Chronic Kidney Disease Drugs Market Size, 2016-2027
6.7.4 Argentina Chronic Kidney Disease Drugs Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Chronic Kidney Disease Drugs Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Chronic Kidney Disease Drugs Sales, 2016-2027
6.8.3 Turkey Chronic Kidney Disease Drugs Market Size, 2016-2027
6.8.4 Israel Chronic Kidney Disease Drugs Market Size, 2016-2027
6.8.5 Saudi Arabia Chronic Kidney Disease Drugs Market Size, 2016-2027
6.8.6 UAE Chronic Kidney Disease Drugs Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Keryx Biopharmaceuticals, Inc
7.1.1 Keryx Biopharmaceuticals, Inc Corporate Summary
7.1.2 Keryx Biopharmaceuticals, Inc Business Overview
7.1.3 Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Major Product Offerings
7.1.4 Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Sales and Revenue in Global (2016-2021)
7.1.5 Keryx Biopharmaceuticals, Inc Key News
7.2 Kissei Pharmaceutical Co., Ltd
7.2.1 Kissei Pharmaceutical Co., Ltd Corporate Summary
7.2.2 Kissei Pharmaceutical Co., Ltd Business Overview
7.2.3 Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Major Product Offerings
7.2.4 Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Sales and Revenue in Global (2016-2021)
7.2.5 Kissei Pharmaceutical Co., Ltd Key News
7.3 AbbVie
7.3.1 AbbVie Corporate Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Chronic Kidney Disease Drugs Major Product Offerings
7.3.4 AbbVie Chronic Kidney Disease Drugs Sales and Revenue in Global (2016-2021)
7.3.5 AbbVie Key News
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Corporate Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Chronic Kidney Disease Drugs Major Product Offerings
7.4.4 GlaxoSmithKline Chronic Kidney Disease Drugs Sales and Revenue in Global (2016-2021)
7.4.5 GlaxoSmithKline Key News
7.5 Sanofi
7.5.1 Sanofi Corporate Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Chronic Kidney Disease Drugs Major Product Offerings
7.5.4 Sanofi Chronic Kidney Disease Drugs Sales and Revenue in Global (2016-2021)
7.5.5 Sanofi Key News
7.6 F. Hoffmann-La Roche Ltd
7.6.1 F. Hoffmann-La Roche Ltd Corporate Summary
7.6.2 F. Hoffmann-La Roche Ltd Business Overview
7.6.3 F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Major Product Offerings
7.6.4 F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Sales and Revenue in Global (2016-2021)
7.6.5 F. Hoffmann-La Roche Ltd Key News
7.7 Pfizer
7.7.1 Pfizer Corporate Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Chronic Kidney Disease Drugs Major Product Offerings
7.4.4 Pfizer Chronic Kidney Disease Drugs Sales and Revenue in Global (2016-2021)
7.7.5 Pfizer Key News
7.8 AstraZeneca
7.8.1 AstraZeneca Corporate Summary
7.8.2 AstraZeneca Business Overview
7.8.3 AstraZeneca Chronic Kidney Disease Drugs Major Product Offerings
7.8.4 AstraZeneca Chronic Kidney Disease Drugs Sales and Revenue in Global (2016-2021)
7.8.5 AstraZeneca Key News
7.9 Amgen
7.9.1 Amgen Corporate Summary
7.9.2 Amgen Business Overview
7.9.3 Amgen Chronic Kidney Disease Drugs Major Product Offerings
7.9.4 Amgen Chronic Kidney Disease Drugs Sales and Revenue in Global (2016-2021)
7.9.5 Amgen Key News
7.10 Teva Pharmaceutical Industries
7.10.1 Teva Pharmaceutical Industries Corporate Summary
7.10.2 Teva Pharmaceutical Industries Business Overview
7.10.3 Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Major Product Offerings
7.10.4 Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Sales and Revenue in Global (2016-2021)
7.10.5 Teva Pharmaceutical Industries Key News
8 Global Chronic Kidney Disease Drugs Production Capacity, Analysis
8.1 Global Chronic Kidney Disease Drugs Production Capacity, 2016-2027
8.2 Chronic Kidney Disease Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Chronic Kidney Disease Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Chronic Kidney Disease Drugs Supply Chain Analysis
10.1 Chronic Kidney Disease Drugs Industry Value Chain
10.2 Chronic Kidney Disease Drugs Upstream Market
10.3 Chronic Kidney Disease Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Chronic Kidney Disease Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Chronic Kidney Disease Drugs in Global Market
Table 2. Top Chronic Kidney Disease Drugs Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Chronic Kidney Disease Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Chronic Kidney Disease Drugs Revenue Share by Companies, 2016-2021
Table 5. Global Chronic Kidney Disease Drugs Sales by Companies, (K MT), 2016-2021
Table 6. Global Chronic Kidney Disease Drugs Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Chronic Kidney Disease Drugs Price (2016-2021) & (USD/MT)
Table 8. Global Manufacturers Chronic Kidney Disease Drugs Product Type
Table 9. List of Global Tier 1 Chronic Kidney Disease Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chronic Kidney Disease Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
Keryx Biopharmaceuticals, Inc
Kissei Pharmaceutical Co., Ltd
AbbVie
GlaxoSmithKline
Sanofi
F. Hoffmann-La Roche Ltd
Pfizer
AstraZeneca
Amgen
Teva Pharmaceutical Industries